Tolerability, Safety, and Quality of Life with Tapentadol Prolonged Release (
PR
) Compared with Oxycodone/Naloxone
PR
in Patients with Severe Chronic Low Back Pain with a Neuropathic Component: A Randomized, Controlled, Open‐label, Phase 3b/4 Trial
Keyword(s):
Low Back
◽
2011 ◽
Vol 5
(S1)
◽
pp. 85-85
Keyword(s):